News Releases


Honeywell Secures Global Rights from Dupont on Replacement for Ozone-Depleting R-22 Refrigerant

Allows Honeywell to sell R-422D as replacement for R-22 in refrigeration and air-conditioning systems.

MORRIS TOWNSHIP, N.J., Oct. 15, 2008 - Honeywell (NYSE: HON) announced today it has secured global rights from DuPont allowing Honeywell to sell R-422D, a replacement for R-22 in refrigeration and air-conditioning systems.

R-422D is a non-ozone-depleting hydrofluorocarbon (HFC) refrigerant that is an efficient and cost-effective retrofit solution for replacing ozone-depleting R-22 in existing systems. Honeywell will sell R-422D under the Genetron® refrigerants brand name.

"This global agreement allows Honeywell to provide additional solutions for its customers all over the world who must meet regulatory requirements to phase-out ozone-deplete substances," said David Diggs, global business director for the refrigerants business of Honeywell Fluorine Products.

Under the Montreal Protocol, all signatory nations have agreed to phase-out the use of ozone-depleting substances, including chlorofluorocarbons (CFCs) and hydrochlorofluorocarbons (HCFCs). The European Union has aggressively implemented this change. In 2003, it banned new systems from using R-22, a HCFC refrigerant. Additionally, in 2010 the production of R-22 for refrigeration and air-conditioning applications for service of existing equipment will also be prohibited. Owners of R-22 based equipment will either need to service the equipment with recycled/reclaimed R-22, use a retro-fit fluid such as R-422D or replace the equipment. Other countries are also implementing the phase-out of R-22.

Honeywell's Fluorine Products business is a leader in the manufacture and supply of zero ozone-depleting refrigerants used by top air-conditioning and refrigeration makers worldwide and blowing agents for energy-efficient foam insulation, as well as hydrofluoric acid and precursors for nuclear fuel.

Honeywell Specialty Materials, based in Morristown, N.J., is a $4.9 billion, global leader in providing customers with high-performance specialty materials, including fluorine products; specialty films and additives; advanced fibers and composites; intermediates; specialty chemicals; electronic materials and chemicals; and technologies and materials for petroleum refining.

Honeywell International is a $38 billion diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; specialty chemicals; fibers; and electronic and advanced materials. Based in Morris Township, NJ, Honeywell's shares are traded on the New York, London, Chicago and Pacific Stock Exchanges. It is a component of the Standard & Poor's 500 Index. For additional information, please visit www.honeywell.com.

This report contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements are based on management's assumptions and assessments in light of past experience and trends, current conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by our forward-looking statements. Our forward-looking statements are also subject to risks and uncertainties, which can affect our performance in both the near- and long-term. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.

Media Contacts:
U.S.
Peter Dalpe
(973) 455-4908
peter.dalpe@honeywell.com

Europe
Sabine Chmielewski
+49 (0) 5137-999-9411
sabine.chmielewski@honeywell.com